SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Market Cap	3.95B
Revenue (ttm)	1.26B
Net Income (ttm)	393.28M
Shares Out	44.59M
EPS (ttm)	8.80
PE Ratio	10.07
Forward PE	n/a
Dividend	5.30 (6.19%)
Ex-Dividend Date	Jul 19, 2024

Volume	29,283
Average Volume	162,057
Open	87.70
Previous Close	89.00
Day's Range	87.70 - 89.40
52-Week Range	81.80 - 110.00
Beta	0.00
RSI	41.93
Earnings Date	Mar 7, 2025

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, antiulcerative, antihypertensive, α- blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anest...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1982
• Employees: 227
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1777

Financial Performance

In 2024, SYN-TECH Chem. & Pharm.'s revenue was 1.26 billion, an increase of 12.83% compared to the previous year's 1.11 billion. Earnings were 393.28 million, an increase of 56.68%.